Islet cell dysfunction in patients with chronic pancreatitis.

作者: Ayan Roy , Jayaprakash Sahoo , Sadishkumar Kamalanathan , Dukhabandhu Naik , Pazhanivel Mohan

DOI: 10.4239/WJD.V11.I7.280

关键词:

摘要: Chronic pancreatitis (CP) is characterized by progressive inflammation and fibrosis of the pancreas that eventually leads to pancreatic exocrine endocrine insufficiency. Diabetes in background CP very difficult manage due high glycemic variability concomitant malabsorption. Progressive beta cell loss leading insulin deficiency cardinal mechanism underlying diabetes development CP. Alpha dysfunction deranged glucagon secretion has been described different studies using a variety stimuli However, emerging evidence varied probably because dependence on study procedure, population as well stage disease. The behind islet multifactorial. intra-islet alpha regulation each other often lost. Moreover, incretin hormones such like peptide-1 glucose-dependent insulinotropic polypeptide dysregulated. This significantly contributes disturbances. Persistent with changes function cells delta are also implicated In addition, surgical procedures performed patients antihyperglycemic drugs used treat associated affect function. Hence, factors chronic inflammation, dysregulated axis, interventions anti-diabetic all Newer therapies targeting regeneration would be useful management near future.

参考文章(77)
J.W. Heise, H. Becker, C. Niederau, H.D. R�her, Einfluß von Resektion oder Gangdrainage auf die glukosestimulierte β-Zellfunktion bei chronischer Pankreatitis Langenbeck's Archives of Surgery. ,vol. 379, pp. 44- 49 ,(1994) , 10.1007/BF00206561
Omid Savari, Karolina Golab, Ling-Jia Wang, Lindsay Schenck, Randall Grose, Martin Tibudan, Sabarinathan Ramachandran, W. James Chon, Mitchell C. Posner, J. Michael Millis, Jeffrey B. Matthews, Andres Gelrud, Piotr Witkowski, Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. American Surgeon. ,vol. 81, pp. 421- 427 ,(2015) , 10.1177/000313481508100435
Riddhi Dasgupta, Dukhabandhu Naik, Nihal Thomas, Emerging concepts in the pathogenesis of diabetes in fibrocalculous pancreatic diabetes. Journal of Diabetes. ,vol. 7, pp. 754- 761 ,(2015) , 10.1111/1753-0407.12280
Yutaka Seino, Mitsuo Fukushima, Daisuke Yabe, GIP and GLP‐1, the two incretin hormones: Similarities and differences Journal of Diabetes Investigation. ,vol. 1, pp. 8- 23 ,(2010) , 10.1111/J.2040-1124.2010.00022.X
N. Ewald, C. Kaufmann, A. Raspe, H. U. Kloer, R. G. Bretzel, P. D. Hardt, Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c) Diabetes-metabolism Research and Reviews. ,vol. 28, pp. 338- 342 ,(2012) , 10.1002/DMRR.2260
J. Linde, L. H:son Nilsson, F. R. Barany, Diabetes and hypoglycemia in chronic pancreatitis Scandinavian Journal of Gastroenterology. ,vol. 12, pp. 369- 373 ,(1977) , 10.3109/00365527709180943
V. Kannan, J.D.N. Nabarro, P.B. Cotton, Glucagon Secretion in Chronic Pancreatitis Hormone Research in Paediatrics. ,vol. 11, pp. 203- 212 ,(1979) , 10.1159/000179055
Giuseppe Garcea, James Weaver, John Phillips, Cristina A. Pollard, Severine C. Ilouz, M'Balu A. Webb, David P. Berry, Ashley R. Dennison, Total pancreatectomy with and without islet cell transplantation for chronic pancreatitis: a series of 85 consecutive patients. Pancreas. ,vol. 38, pp. 1- 7 ,(2009) , 10.1097/MPA.0B013E3181825C00
Ranjit Unnikrishnan, Viswanathan Mohan, Fibrocalculous pancreatic diabetes (FCPD) Acta Diabetologica. ,vol. 52, pp. 1- 9 ,(2015) , 10.1007/S00592-014-0685-9